DISABILITY ACCOMMODATION | 2026-11-15
Medical Cannabis Accommodation After Ross and AB 2188 in California 2026
Ross v. RagingWire still bars on-the-job impairment while AB 2188 now protects lawful off-duty cannabis use under Government Code 12954.
By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published
For years California employers could fire a worker for off-duty medical marijuana use under Ross v. RagingWire. AB 2188 and SB 700 changed that for most roles effective 2024. The two developments coexist: Ross still means no right to be impaired at work, while Government Code 12954 now generally bar
Cannabis and the California Workplace After Ross and AB 2188
For years the rule in California was stark: an employer could fire a worker for using medical marijuana, even for a doctor-recommended condition, and even where the use happened off duty and off site. That was the holding of Ross v. RagingWire Telecommunications (2008). A decade and a half later the Legislature changed the landscape. Assembly Bill 2188, together with Senate Bill 700, added new off-duty cannabis protections to the Fair Employment and Housing Act effective January 1, 2024. The two developments do not cancel each other out. Ross still tells employees there is no right to be impaired at work, while the new statute tells employers they generally may not punish lawful off-duty, off-site cannabis use or rely on tests that detect only nonpsychoactive metabolites. Understanding how these pieces fit is now essential for every California workplace.
This guide explains what Ross decided, what AB 2188 and SB 700 added at Gov. Code § 12954, the exceptions for safety-sensitive and federally regulated roles, the difference between impairment and lingering metabolites, and the remedies available to an employee who is disciplined for protected off-duty use.
What Ross v. RagingWire Decided
In Ross v. RagingWire Telecommunications (2008), the California Supreme Court held that the Fair Employment and Housing Act did not require an employer to accommodate an employee's use of medical marijuana. The plaintiff used marijuana on a physician's recommendation under the Compassionate Use Act, Health & Safety Code § 11362.5, to treat chronic pain. He failed a pre-employment drug test and lost the job. The Court reasoned that the Compassionate Use Act provided a defense to state criminal prosecution but did not create employment protections, and that FEHA did not obligate an employer to accommodate the use of an illegal drug, since marijuana remained illegal under federal law. Ross thus established that, absent a statute to the contrary, an employer could enforce a drug-free policy against medical cannabis users.
The Gap Ross Left and the Legislature's Response
For fifteen years, Ross meant a worker could be qualified, productive, and law-abiding under state law yet still lose a job over a positive marijuana test that reflected off-duty use days earlier. The problem was aggravated by the chemistry of testing. Standard urine tests detect nonpsychoactive cannabis metabolites that can linger in the body long after any impairing effect has passed. A positive result therefore said little about whether the employee was impaired at work; it often reflected lawful weekend use. The Legislature addressed this gap with Assembly Bill 2188, supplemented by Senate Bill 700.
What AB 2188 and Gov. Code § 12954 Now Prohibit
Effective January 1, 2024, Gov. Code § 12954 makes it unlawful for an employer to discriminate against a person in hiring, termination, or any term or condition of employment, or otherwise penalize a person, in two situations. First, the employer may not act based on the person's use of cannabis off the job and away from the workplace. Second, the employer may not act based on an employer-required drug screening test that has found the person to have nonpsychoactive cannabis metabolites in their hair, blood, urine, or other bodily fluids. The statute reflects the scientific reality that the presence of a nonpsychoactive metabolite does not indicate current impairment. Senate Bill 700 added a related protection making it generally unlawful for an employer to request information from an applicant about prior cannabis use, subject to the statute's exceptions.
The design of the protection is important. The statute does not give employees a right to use cannabis at work or to be impaired on the job. It protects lawful off-duty, off-site conduct and bars reliance on a particular, non-probative kind of test result. An employer may still maintain a policy prohibiting possession, use, or impairment during work hours.
It is worth stressing what the statute does not do. It does not legalize cannabis under federal law, it does not require an employer to permit use on the premises, and it does not shield an employee who arrives at work impaired. What it does is draw a clear boundary around the employer's authority: the employer governs the workplace and the working hours, while the employee's lawful conduct on their own time, in their own space, is generally no longer a permissible basis for employment decisions in non-exempt roles. That boundary mirrors how California already treats other forms of lawful off-duty conduct, and it brings cannabis into line with the principle that an employer's control over private life ends at the point where the conduct has no bearing on job performance or workplace safety.
Pre-Employment Inquiries and SB 700
Senate Bill 700 closed a gap that AB 2188 alone left open. Even if an employer could not act on a metabolite test, it might have asked applicants directly about prior cannabis use and screened them out that way. SB 700 addressed this by amending FEHA to make it generally unlawful for an employer to request information from an applicant relating to the applicant's prior use of cannabis, subject to the same exceptions that govern Gov. Code § 12954. The practical effect is that application forms, background questionnaires, and interview scripts for protected roles must be scrubbed of questions about past marijuana use. Information about cannabis use obtained from a lawfully conducted criminal background check, consistent with other law, is treated differently, but a direct question to the applicant about prior use is off limits for covered positions. Employers that still ask such questions create an independent basis for liability even if they never administer a metabolite test.
Impairment Testing That Remains Lawful
Because the statute targets nonpsychoactive metabolite testing, employers retain the ability to use scientifically valid methods that measure current impairment or detect the psychoactive component of cannabis. The statute contemplates that an employer may use an impairment test that measures an individual employee against their own baseline performance, or a test that identifies the presence of tetrahydrocannabinol in a way that indicates recent use rather than mere past exposure. An employer with a legitimate concern about on-the-job impairment can therefore still test, but it should use a method that actually bears on impairment rather than one that flags lawful off-duty use.
The Exceptions: Safety-Sensitive and Federally Regulated Roles
Gov. Code § 12954 carves out significant exceptions. The protections do not apply to employees in the building and construction trades, and they do not apply to applicants or employees in positions that require a federal background investigation or clearance. Critically, the statute does not preempt state or federal laws that require applicants or employees to be tested for controlled substances, including laws and regulations that require testing as a condition of employment, receipt of federal funding or licensing, or entering into a federal contract. This exception preserves the testing regimes that govern commercial drivers under United States Department of Transportation rules and other federally regulated, safety-sensitive positions. For a worker in one of those roles, the old reality persists: a positive test can still cost the job, because federal law controls.
Reasonable Suspicion, Observed Impairment, and Documentation
Because the lawful path to addressing cannabis at work runs through impairment rather than metabolite testing, employers and employees alike should understand how observed impairment is properly documented. A supervisor who suspects an employee is impaired on the job should record specific, objective observations: slurred speech, unsteadiness, the odor of cannabis, bloodshot eyes, errors in a safety-critical task, or a near-miss incident. Those contemporaneous observations, not a laboratory metabolite result, are what support a lawful reasonable-suspicion response and any discipline for on-the-job impairment. For the employee, the same principle offers protection: if an employer cannot point to observed signs of present impairment and instead relies solely on a positive metabolite screen for a non-exempt role, the discipline likely violates Gov. Code § 12954. The shift the statute requires is from chemistry that detects past exposure to behavior that reflects present impairment, and careful documentation is what keeps an employer on the right side of that line.
The Continuing Relevance of the Compassionate Use Act
The Compassionate Use Act, Health & Safety Code § 11362.5, still provides the state-law foundation for medical cannabis, protecting qualified patients from state criminal liability for use recommended by a physician. But as Ross made clear, that criminal-law protection never created an employment right. AB 2188 supplies the employment protection that the Compassionate Use Act did not, and it does so for cannabis use generally, not only medical use, subject to the statute's exceptions. A medical patient and a recreational user who both use lawfully off duty now enjoy the same core protection against metabolite-based discipline.
How Ross and AB 2188 Coexist
The two authorities govern different questions. Ross answers whether an employer must tolerate impairment or accommodate use at work, and the answer remains no. AB 2188 answers whether an employer may punish lawful off-duty, off-site use or rely on a metabolite test, and the answer is now generally no, outside the statutory exceptions. An employer that disciplines an employee for being impaired on the job, or for possessing cannabis at work, stands on ground Ross left intact. An employer that fires an employee solely because a urine test showed nonpsychoactive metabolites from weekend use now violates Gov. Code § 12954. The line is impairment and workplace conduct on one side, lawful off-duty use on the other.
Remedies for an Employee Disciplined for Protected Use
Because the protection lives in FEHA, a violation of Gov. Code § 12954 is enforced like other FEHA claims. An employee must first exhaust the administrative requirement by filing with the Civil Rights Department and obtaining a right-to-sue notice, then may sue in superior court. FEHA remedies include lost wages and benefits, emotional distress damages, injunctive relief, and attorney fees under Gov. Code § 12965. An applicant who was denied a job because of a metabolite test, or an employee fired for off-duty use, should preserve the test results, the testing methodology, the job description, and any statements by the employer about why the action was taken, since the lawfulness of the discipline often turns on whether the test measured impairment or mere past exposure.
Compliance Steps for California Employers
Employers should audit their drug-testing programs to ensure they are not relying on nonpsychoactive metabolite results to make employment decisions for non-exempt roles. They should distinguish safety-sensitive and federally regulated positions, which remain subject to mandatory testing, from ordinary positions now protected by Gov. Code § 12954. Policies should prohibit impairment and possession at work rather than off-duty use, pre-employment questionnaires should be scrubbed of improper cannabis-history questions consistent with SB 700, and supervisors should be trained to document observed impairment rather than to rely on a positive metabolite screen. An employer that maintains a legitimate impairment standard and uses appropriate testing can protect safety without running afoul of the new law. Workers facing related accommodation questions about lawful conduct and recovery may also consult our analysis of rehabilitation leave under Labor Code 1025, and can follow developments on our California employment law news page.
The Doctrine Before the Statute: Preemption and the Illegal-Drug Rationale
To understand why AB 2188 was necessary, it helps to see the full reasoning of Ross v. RagingWire Telecommunications (2008). The California Supreme Court rested its holding on two pillars. First, the Compassionate Use Act, Health & Safety Code § 11362.5, was enacted to shield qualified patients from state criminal prosecution, and nothing in its text or history suggested the voters intended to regulate the employment relationship. Second, marijuana remained illegal under federal law, and the Court declined to read FEHA to require employers to accommodate the use of a substance that federal law prohibited. Those pillars left medical cannabis users with no employment protection for fifteen years, even for off-duty use that bore no relationship to job performance. The Legislature did not overrule Ross so much as legislate around it, creating a targeted employment protection that the Compassionate Use Act never supplied and that Ross said FEHA did not then require. This is why the two authorities coexist rather than conflict: Ross interpreted the law as it stood, and the Legislature then changed the law.
Discrimination, Terms, and Conditions Under the New Statute
Gov. Code § 12954 does more than bar wrongful termination; it reaches the full range of employment decisions. The statute makes it unlawful to discriminate against a person in hiring, in termination, or in any term or condition of employment, as well as to otherwise penalize a person, based on protected off-duty use or on a prohibited metabolite test. That breadth means an employer cannot sidestep the law by, for example, denying a promotion, reducing hours, reassigning to a worse shift, or imposing discipline short of termination because of lawful off-duty cannabis use. The protection also folds into the FEHA enforcement structure, so the full set of FEHA remedies and procedures applies. Employers that think of the statute only as a rule about firing miss its reach into every stage of the employment relationship, from the application to the exit.
A Worked Example: The Weekend User and the Pre-Employment Screen
Consider an applicant for an office analyst position who uses cannabis lawfully on a Saturday evening at home and interviews the following Thursday. The employer extends a conditional offer and requires a standard urine screen, which flags nonpsychoactive metabolites from the weekend use, and the employer rescinds the offer. Because the analyst role is not in the building and construction trades, requires no federal clearance, and is not subject to a federal testing mandate, Gov. Code § 12954 generally makes it unlawful to rescind the offer based on that metabolite result or on the off-duty use it reflects. The applicant has a FEHA claim. Now change the role to a commercial truck driver subject to United States Department of Transportation testing. There the federal mandate controls, the statutory exception applies, and the same positive result can lawfully cost the job. The two scenarios show that the role, not the conduct, often decides the outcome.
Why the Science of Metabolite Testing Drove the Law
The Legislature singled out nonpsychoactive metabolite testing because such tests do not measure impairment. Tetrahydrocannabinol is the psychoactive compound, but the body metabolizes it into inactive byproducts that persist in urine, hair, and other fluids for days or weeks after any effect has worn off. A positive metabolite screen therefore tells an employer that a person used cannabis at some point, not that the person is impaired now or was impaired at work. Gov. Code § 12954 reflects that reality by barring reliance on these non-probative results while preserving the employer's ability to use methods that actually bear on current impairment. For employers, the practical lesson is to replace or supplement metabolite screens with impairment-focused assessments for non-exempt roles.
Drafting a Compliant Drug Policy
A compliant California policy for non-exempt roles prohibits possession, use, and impairment during work hours and on work premises, reserves the right to test for current impairment on reasonable suspicion, and does not condition employment on the absence of nonpsychoactive metabolites. The policy should carve out and clearly identify the roles that remain subject to mandatory federal or state testing, so that safety-sensitive and federally regulated positions are handled under the correct regime. Consistent with Senate Bill 700, application forms and interview scripts should omit questions about prior cannabis use for protected roles. Supervisors should be trained to document observed signs of impairment, such as specific behavioral and performance indicators, rather than to rely on a laboratory metabolite result.
Employee Steps After an Adverse Action
An employee or applicant who believes a cannabis-related decision violated Gov. Code § 12954 should gather the test result and, if possible, the testing methodology, the job description showing the role is not exempt, the timeline of the offer or discipline, and any employer statements about the reason. Because the right is in FEHA, the worker must file with the Civil Rights Department and obtain a right-to-sue notice before filing suit, and should be mindful of the filing deadlines that govern FEHA charges. Early documentation matters because the central question is usually whether the test measured impairment or merely past exposure, a point best proven with the lab report in hand.
Talk to a California employment lawyer. If you lost a job offer or your job because of a cannabis test that detected only off-duty use, or if you are an employer updating a drug-testing policy to comply with Gov. Code § 12954, the attorneys at Trembach Law Firm can assess whether the discipline was lawful and what remedies may apply. Call (213) 645-2246 for a confidential consultation.
Frequently Asked Questions
Does Ross v. RagingWire still mean I can be fired for cannabis?
Ross (2008) still means there is no right to be impaired at work or to use cannabis on the job, and FEHA does not require accommodation of on-the-job use. But AB 2188 now protects lawful off-duty, off-site use for most roles, so a firing based solely on a metabolite test from weekend use is generally unlawful under Gov. Code § 12954.
Can my employer still drug test me?
Yes, but for non-exempt roles the employer generally may not base decisions on tests that detect only nonpsychoactive metabolites. Employers may use methods that measure current impairment or detect the psychoactive component indicating recent use.
Which jobs are not protected by AB 2188?
The protections do not apply to the building and construction trades or to positions requiring a federal background investigation or clearance, and they do not override state or federal testing mandates, such as United States Department of Transportation rules for commercial drivers.
Does the Compassionate Use Act protect my job?
No. Health & Safety Code § 11362.5 protects qualified patients from state criminal liability but, as Ross held, never created employment protections. The employment protection comes from Gov. Code § 12954.
How do I enforce a violation of the off-duty cannabis protection?
Because the right is in FEHA, you file with the Civil Rights Department, obtain a right-to-sue notice, and may then sue. FEHA remedies under Gov. Code § 12965 include lost wages, emotional distress damages, injunctive relief, and attorney fees.
This article is provided for general informational purposes only and is not legal advice. Reading it does not create an attorney-client relationship. Every case depends on its own facts, and no particular outcome is guaranteed.
Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.
Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301